The effect of prolonged exposure to the antibiotic meropenem on the resistance characteristics of Acinetobacter baumannii in vitro
Main Article Content
Keywords
Acinetobacter baumannii, antimicrobial resistance, meropenem
Abstract
Introduction: To prove the effect of prolonged exposure to the antibiotic meropenem on the emergence of Acinetobacter baumannii resistance in vitro.
Methods: Meropenem-susceptible Acinetobacter baumannii isolates were exposed to 0.1 mg/ml meropenem and incubated for 8 days. The optical density and number of Acinetobacter baumannii bacterial colonies were observed every 24 hours. The average of optical density and the number of Acinetobacter baumannii bacterial colonies growing every 24 hours were analyzed using the Kruskal-Wallis test.
Results: The results showed a decrease in the average optical density value and the number of Acinetobacter baumannii bacterial colonies from day 1 to day 6 of incubation. However, there was an increase in the average optical density and the number of Acinetobacter baumannii bacterial colonies starting on day 7 and day 8.
Conclusions: Exposure to the antibiotic meropenem 0.1 mg/ml for 6 days might be associated with the emergence of Acinetobacter baumannii resistance in vitro.
References
2. WHO. Buku antibiotika WHO AWaRe(Access, Watch, Reserve). 2022. WHO regional office for South-East Asia.
3. Kuntaman; Karuniawati AG wani;et. all. Surveilans resistansi antibiotik rumah sakit di Indonesia tahun 2021. 2022. Perhimpunan Dokter Spesialis Mikrobiologi Klinik Indonesia (PAMKI).
4. Shabna F,S Satish. A review on Meropenem resistance: Current trends and clinical implications. Int J in Pharm Sci. 2023;1(11):551-561.
5. Lourenço da Fonseca É, Mascarenhas Morgado S, dos Santos F, C Oliveira PP, Monteiro PM, Lima LS, et al. Outbreak of a carbapenem-resistant XDR Acinetobacter baumannii belonging to the International Clone II (IC2) in a clinical setting in Brazil, 2022.2023. Available from: https://doi.org/10.1101/2023.05.12.23289862
6. Fadrian. Antibiotik, infeksi dan resistensi. 2023. Andalas University Press. Padang.
7. Queenan AM, Bush K. Carbapenemases: The versatile β-lactamaseClinical Microbiology Reviews. 2007; 20 (3):440–58.
8. Singh H, Thangaraj P, Chakrabarti A. Acinetobacter baumannii: A brief account of mechanisms of multidrug resistance and current and future therapeutic management. Journal of Clinical and Diagnostic Research. 2013;7:2602–5.
9. Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial antibiotic resistance: the most critical pathogens. Pathogens. MDPI; 2021;10:1310. Available from: https://doi.org/10.3390/pathogens10101310
10. Lewis J. M100 Performance Standards For Antimicrobial Susceptibility Testing, 33rd Edition,M100ed33. CLSI; 2023.
11. Hawkey J, Ascher DB, Judd LM, Wick RR, Kostoulias X, Cleland H, et al. Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection. Microbial genomics 2018;4. Available from: https://doi.org/10.4225/
12. Balázs B, Tóth Z, Nagy F, Kovács R, Tóth H, Nagy JB, et al. The role of uniform meropenem usage in acinetobacter baumannii clone replacement. Antibiotics. 2021;10(2):1–12.
13. Rivani E, Endraswari PD, Widodo ADW. Growth kinetics of multiple Acinetobacter baumannii resistotype after meropenem-based antibiotic combination exposure. F1000Res. 2022 Jul 8;11:762.
14. Sabet M, Tarazi Z, Griffith DC. Pharmacodynamics of Meropenem against Acinetobacter baumannii in a neutropenic mouse thigh infection model. Antimicrob Agents Chemother. 2020;64(4): e022388-19.
15. Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi Journal of Biological Sciences. Elsevier B.V.; 2018;25:586–96.
16. Nguyen M, Joshi SG. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. Journal of Applied Microbiology. 2021;131:2715–38.
17. Papadopoulou M, Deliolanis I, Polemis M, Vatopoulos A, Psichogiou M, Giakkoupi P. Characteristics of the Genetic Spread of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Greek Hospital. 2024;15:458. Available from: https://www.mdpi.com/2073-4425/15/4/458
18. Yusuf E, Van Herendael B, Verbrugghe W, Ieven M, Goovaerts E, Bergs K, et al. Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration. Ann Intensive Care. 2017;7:72.